Clinical Guides
Dementia
An India-adapted clinical guide to evaluating acquired cognitive and functional decline, identifying dementia subtype and reversible contributors, and planning person-centred long-term care.
MedNext Academy | 13 min read
Dementia
An India-adapted clinical guide to evaluating acquired cognitive and functional decline, identifying dementia subtype and reversible contributors, and planning person-centred long-term care.
Summary
Dementia describes an acquired decline in one or more cognitive domains that interferes with independent everyday function and is not explained solely by delirium. Memory loss is common but not universal at onset: executive, language, visuospatial, behavioural or social-cognitive change may dominate. Alzheimer's disease is the most frequent degenerative cause internationally; vascular dementia, dementia with Lewy bodies and frontotemporal dementia are important subtypes, and mixed pathology is common in older adults. Dementia is not an inevitable consequence of ageing. Diagnosis requires a history of change from the person and someone who knows them, assessment of cognition and function, physical and neurological examination, medication review and investigation for treatable contributors. A brief cognitive score alone cannot confirm or exclude it.
At every stage, distinguish chronic decline from acute delirium, depression, sensory loss, medicine effects and other neurological or systemic disease. Rapid progression, seizures, focal signs or onset at a young age need timely specialist investigation. Management is person-centred and combines explanation, care coordination, meaningful activity, cognitive and functional support, vascular risk care, treatment of comorbidity and sustained support for carers. Cognitive-enhancing medicines have subtype-specific indications and modest average effects; they neither cure dementia nor replace non-drug care. Behavioural and psychological symptoms require assessment for pain, delirium, unmet needs and environmental triggers before psychotropics. Discuss driving, finances, capacity, safeguarding and advance care early, while the person can express preferences. [DEM-1]
How Common Is It?
Dementia becomes more frequent with advancing age, but prevalence estimates depend on age structure, case definition, survey method, survival and access to diagnosis. An estimate from a memory clinic or another country should not be presented as a national Indian rate. India has a large and diverse older population, substantial rural residence, wide variation in literacy and multiple languages; cognitive tests and service data therefore require culturally and educationally appropriate interpretation. Under-recognition is plausible where families normalise decline, stigma delays consultation, or specialist services are distant, while referral-centre samples over-represent complex disease.
The burden extends beyond the number diagnosed. Cognitive decline affects medication use, finances, cooking, travel, personal care and vulnerability to injury or exploitation. Family members often provide prolonged unpaid care and may experience sleep loss, depression, financial strain and interrupted employment. Dementia also increases vulnerability to delirium during illness or hospital admission. Population statistics describe groups, not the prognosis of an individual: course varies by subtype, comorbidity, frailty and social support. Younger-onset dementia is uncommon but has distinct employment, parenting and genetic implications and deserves specialist assessment rather than dismissal. Public-health work should support risk reduction across the life course and earlier recognition without implying that every case is preventable. Clinically, the useful question is whether there has been a persistent decline from this person's prior cognitive ability with loss of everyday function, supported by reliable collateral history. [DEM-2]
Risk Factors
Age is the strongest population-level risk factor, but age alone does not diagnose dementia. Family history and some genetic variants alter risk, with highly penetrant inherited disorders accounting for only a minority of cases. Vascular risks including hypertension, diabetes, smoking, dyslipidaemia, obesity and previous stroke contribute particularly to vascular and mixed cognitive impairment. Hearing loss, low educational opportunity, social isolation, physical inactivity, depression and traumatic brain injury are associated with later cognitive decline, although observational association does not prove that changing one factor will prevent an individual case. Protective advice should avoid blame and should remain feasible for disability, poverty and local access.
Clinical risk assessment also considers Parkinson disease, Down syndrome, HIV, alcohol-related brain injury, epilepsy, recurrent delirium and medicines with anticholinergic or sedative effects. Sleep apnoea, thyroid disease, vitamin deficiency, renal or hepatic dysfunction, sensory impairment and depression may worsen cognition and sometimes partly reverse with treatment; finding one contributor does not exclude coexisting neurodegeneration. A stepwise or fluctuating course, focal neurological history and vascular burden support vascular contribution. Visual hallucinations, cognitive fluctuations, REM-sleep behaviour symptoms and spontaneous parkinsonism raise concern for Lewy body disease. Early personality, conduct or language change may suggest frontotemporal degeneration. Risk factors guide probability and investigation but cannot substitute for evidence of cognitive-functional decline. Ask about safety, alcohol, medicines, falls, driving, financial decisions and the effect of illness on both the person and their carer. [DEM-1]
Diagnosis
History
Describe onset, sequence and progression across memory, language, attention, planning, visuospatial skills, behaviour and mood. Establish effects on complex activities such as medicines, money, transport, cooking and work, then basic self-care. Interview the person and, with consent where possible, someone who knows their baseline. Ask about acute fluctuation, depression, hallucinations, sleep behaviour, parkinsonism, stroke, seizures, head injury, alcohol, medicines, sensory loss, family history, driving, falls, safeguarding and carer strain.
Examination
Assess appearance, communication, mood, thought, insight and cognition using a validated instrument suited to language, education and sensory ability. Do not rule out dementia because the score is normal. Examine gait, eye movements, tone, tremor, reflexes, coordination, focal signs, cardiovascular status, vision and hearing; look for systemic illness and self-neglect. Assess capacity only for the decision at hand.
Investigations
Use blood and urine tests to evaluate clinically plausible reversible contributors; typical choices may include blood count, electrolytes, renal, liver, thyroid and glucose measures, with vitamin, infection or other testing guided by context. Structural imaging helps exclude a mass, subdural collection, hydrocephalus or major vascular disease and supports subtype assessment; CT may be pragmatic, while MRI gives greater detail when available. Specialist neuropsychology, functional imaging, cerebrospinal-fluid biomarkers, EEG or genetics is selective, not routine for everyone. Confirm subtype when possible after reversible contributors, delirium and depression have been considered. [DEM-1]
Differential Diagnosis
Delirium develops over hours or days, fluctuates and prominently impairs attention or arousal. It is a medical emergency and may occur on top of dementia. Depression can cause reduced concentration, slowed thinking and prominent subjective memory concern; mood history, biological symptoms and longitudinal response help, but depression and dementia can coexist. Mild cognitive impairment denotes objective decline with largely preserved independent function and requires follow-up rather than reassurance that progression cannot occur. Normal ageing may slow recall but should not cause progressive loss of medication management, finances, navigation or self-care. Low literacy, unfamiliar testing language, deafness and visual impairment can lower scores without representing neurodegeneration.
Medication toxicity, alcohol use, sleep apnoea, thyroid disease, vitamin deficiency, renal or hepatic illness, HIV and neurosyphilis are context-dependent considerations. Structural and neurological mimics include subdural haematoma, tumour, normal-pressure hydrocephalus, stroke, epilepsy, autoimmune or infectious encephalitis and prion disease. Rapidly progressive dementia needs urgent neurological evaluation. Subtype clues are probabilistic: early episodic memory impairment supports Alzheimer's disease; stepwise or focal features suggest vascular contribution; recurrent visual hallucinations, fluctuations, REM-sleep behaviour disorder and parkinsonism suggest Lewy body disease; early disinhibition, apathy, loss of empathy or language change suggests frontotemporal dementia. Parkinson disease dementia is diagnosed in the appropriate motor-cognitive sequence. Mixed pathology is common, so force-fitting one label can be misleading. Reassess if the observed course contradicts the initial formulation. [DEM-1]
Management
Give the diagnosis sensitively, assess what the person wants to know and use accessible language. Provide a named coordination route where locally possible and create a written plan covering goals, comorbidity, medicines, safety, function, nutrition, continence, oral health, sensory aids and carer needs. Encourage meaningful activity, social participation and physical activity appropriate to health. Current guidelines supports group cognitive stimulation for mild-to-moderate dementia and considers occupational therapy or cognitive rehabilitation for functional goals. WHO recommends physical activity and conditionally supports selected cognitive or psychological approaches, while acknowledging variable evidence certainty. These interventions support function and wellbeing; they do not promise reversal.
Manage vascular risk, pain, sleep, depression and other illness without therapeutic nihilism. Simplify medication administration, reduce anticholinergic burden and use adherence supports. Assess home hazards, wandering, falls, cooking, finances and vulnerability to abuse. For distress, agitation, hallucinations or aggression, first look for delirium, pain, constipation, infection, hunger, fear, overstimulation, communication difficulty and caregiver exhaustion. Develop personalised non-drug responses based on the person's history and preferences. Support carers with education, communication skills, respite options and assessment of their own health. Review after transitions or functional change. Discuss palliative care as needs-based support from diagnosis, not only in the last days. Swallowing, nutrition and goals of care require individual assessment; routine tube feeding in severe dementia is not supported unless a potentially reversible comorbidity provides a specific indication. [DEM-1]
Prescribing Information
Drug treatment follows subtype, severity, comorbidity and shared decision-making by a qualified clinician. Current guidelines recommends acetylcholinesterase inhibitors for mild-to-moderate Alzheimer's disease and includes memantine for specified moderate disease when these medicines cannot be used and for severe disease. Recommendations differ for dementia with Lewy bodies and vascular dementia; cognitive enhancers should not be prescribed generically for any memory complaint. Expected average benefits are modest and variable. Before and after treatment, review pulse, syncope, weight, gastrointestinal effects, sleep, falls, interactions, adherence and perceived cognitive, functional or behavioural benefit. This guide deliberately provides no product dose or titration schedule.
Review all medicines for anticholinergic and sedative burden and for the ability to take them safely. Do not abruptly stop established psychiatric or neurological treatment from web information. Antipsychotics for agitation, aggression or psychosis carry serious risks, including stroke and mortality in older people with dementia. Current guidelines restricts their use to risk of harm or severe distress from agitation, hallucinations or delusions, after assessment of causes and discussion of benefits and harms. Use the lowest effective dose for the shortest time, reassess at least every six weeks and stop if there is no clear ongoing benefit. Lewy body and Parkinson-related dementias can show severe sensitivity. Valproate is not a routine treatment for agitation in dementia. Treat depression, pain, epilepsy or sleep disorders according to the individual condition, avoiding prescribing cascades and monitoring capacity, consent and carer administration arrangements. [DEM-1]
When to Refer
Refer to a specialist dementia diagnostic service when persistent dementia is suspected after reversible contributors, delirium, depression, sensory impairment and medication effects have been assessed. Referral is more urgent for young onset, rapid progression, atypical cognitive or behavioural features, seizures, focal neurological signs, movement disorder, prominent hallucinations, severe headache, gait-bladder syndrome, suspected inflammatory or infectious disease, or diagnostic uncertainty. Neurology, geriatric medicine, old-age psychiatry, neuropsychology and rehabilitation have complementary roles. A new acute change requires urgent medical assessment for delirium rather than an ordinary memory-clinic wait.
Refer or coordinate additional support when driving safety is uncertain, medicines cannot be managed, nutrition or swallowing is unsafe, falls recur, behaviour places anyone at risk, carer breakdown is imminent, capacity disputes are complex or abuse and financial exploitation are suspected. Palliative-care input is appropriate according to need, symptom burden and goals rather than a rigid cognitive score. In India, available routes may include a primary health centre, district hospital, medical-college medicine, psychiatry or neurology service, geriatric clinic, rehabilitation provider or private specialist. Confirm actual availability, transport and cost. Handover should include time course, cognitive and functional domains, collateral source, examination, tests, medicines, subtype hypothesis, delirium and depression assessment, risks, capacity question, preferred language, family network and carer strain. Do not promise a biomarker, memory clinic or home service that the local system cannot provide. [DEM-2]
Red Flags
An abrupt or fluctuating cognitive change, altered arousal, fever, hypoxia, hypotension, severe glucose disturbance or acute functional collapse suggests delirium and needs urgent medical assessment. Other neurological red flags include a new focal deficit, seizure, recent head trauma, severe or new headache, meningism, rapidly progressive decline over weeks or a few months, prominent early gait disorder with urinary symptoms, and rapidly evolving movement or behavioural abnormalities. Suicidal intent, profound self-neglect, inability to eat or drink, unsafe swallowing, severe medication toxicity and violence creating immediate danger also require urgent action. Dementia should never be used to normalise a new decline.
Safety red flags outside the examination room include getting lost in hazardous places, repeated cooking fires, dangerous driving, medication overdose or omission, unexplained injury, coercion, neglect and sudden unusual financial transactions. Interview the person privately when safe, and do not assume the accompanying relative is necessarily a protective carer. Carer exhaustion, depression, anger or illness may make an otherwise workable plan unsafe and deserves direct assessment. Capacity is decision-specific and cannot be inferred from a diagnosis or cognitive score. Support understanding and communication before concluding that capacity is impaired. When urgent intervention is required, use current Indian law and local policy, choose the least restrictive safe option and document the decision, alternatives and people consulted. New rigidity, fever or reduced consciousness after antipsychotic exposure is a prescribing emergency. [DEM-3]
Indian Clinical Context
Assessment in India must accommodate multilingual communication, variable schooling, joint and dispersed families, rural travel, out-of-pocket cost and uneven specialist access. A cognitive score developed for another language or education level can misclassify a person; interpret it with functional history, adapted communication and collateral evidence. Family members often notice errors in medicines, money or navigation and provide essential care, but diagnosis should not erase the person's voice or make disclosure automatic. Seek consent for information sharing where possible, establish whom the person trusts and recognise that women, widowed people, migrants and financially dependent older adults may have particular safeguarding vulnerabilities.
The Mental Healthcare Act, 2017 supplies a rights-based framework relevant to mental-healthcare capacity, supported communication and advance directives. Dementia itself does not establish incapacity, and a decision that relatives dislike is not by itself proof of incapacity. Legal questions about property, driving, guardianship, consent to general medical treatment and advance planning may engage other current Indian laws and professional duties; use appropriate legal or institutional advice rather than translating UK arrangements. Discuss future care, nominated support, finances and treatment preferences early, while the person can participate, but avoid coercive paperwork. Where formal cognitive rehabilitation, respite or home nursing is unavailable, practical training for family carers, medication simplification, sensory aids, safe routines and planned follow-up can still improve care. Do not claim universal availability of government schemes. Coordinate with primary care and district or medical-college services, and document realistic return precautions and referral routes. [DEM-3]
NMC Competency Mapping
Dementia provides integrated NMC CBME learning across medicine, psychiatry, neurology, community medicine, pharmacology and AETCOM. At Know level, learners should describe acquired cognitive-functional decline, common subtypes, reversible contributors, delirium and depression as differentials, and the distinction from normal ageing and mild cognitive impairment. At Know How level, they should explain why collateral functional history is essential, why a normal brief score does not exclude disease, how imaging contributes without becoming a stand-alone diagnostic test, and why subtype matters for medication and prognosis. Learners should interpret patterns suggesting Alzheimer's, vascular, Lewy body and frontotemporal disease without treating clues as absolute.
At Show How level, learners should take a respectful history from the person and an informant, adapt cognitive assessment for language and sensory needs, perform mental-state, neurological and functional examinations, review medicines, screen for delirium and depression, and present a safe plan. Communication stations can test disclosure, carer support, driving conversations, capacity and advance care. At Perform level, real assessment and prescribing remain supervised and within professional scope. Safe practice includes shared decisions, consent, confidentiality, decision-specific capacity, safeguarding, continuity across care settings and avoiding antipsychotic reflexes for distress. This mapping identifies learning opportunities and does not certify an NMC competency, replace the official curriculum or authorise unsupervised diagnosis. Use the current institutional blueprint and document clinical supervision. [DEM-4]
Key Exam Pearls for NEET PG
Dementia requires decline from a previous level plus interference with everyday independence; a memory complaint or low screening score alone is insufficient. Obtain collateral history and establish instrumental function before basic self-care is lost. A normal brief cognitive test does not exclude dementia, especially with high prior ability, language mismatch or an atypical subtype. Acute fluctuation and inattention indicate delirium until assessed, while prominent low mood and slowed cognition raise depression. Always review hearing, vision, medicines, alcohol and clinically plausible reversible contributors. Structural imaging excludes important lesions and supports subtype assessment but cannot replace the clinical history.
High-yield patterns include early episodic-memory loss in Alzheimer's disease; stepwise decline and focal vascular features; visual hallucinations, fluctuation, REM-sleep behaviour disorder and parkinsonism in dementia with Lewy bodies; and early behavioural or language change in frontotemporal dementia. Mixed disease is common. Cognitive-enhancing medicines have subtype- and severity-specific indications with modest average benefit. For behavioural and psychological symptoms, first seek pain, delirium and unmet needs and use personalised non-drug care. Antipsychotics are reserved for severe distress or risk of harm, require explicit risk-benefit discussion and frequent review, and may cause marked sensitivity in Lewy body disease. Capacity is decision-specific. Discuss driving, finance, safeguarding, carer strain and advance care early rather than waiting for severe impairment. [DEM-1]
Frequently Asked Questions
Does a normal brief cognitive screening score rule out dementia?
No. Screening scores are influenced by education, language, hearing, vision, anxiety, fatigue and prior ability, and some early subtypes affect domains not captured well by a short test. Diagnosis requires evidence of decline from the person's previous cognition and loss of everyday function, supported where possible by someone who knows them. If concern remains despite a normal score, investigate reversible contributors and arrange specialist or neuropsychological assessment appropriate to the presentation.
Which potentially reversible problems should be considered before diagnosing dementia?
First exclude acute delirium and assess depression, sensory impairment, medicine effects, alcohol use, sleep disorders and systemic illness. Blood tests commonly address anaemia, metabolic, renal, liver, thyroid and glucose problems, with vitamin or infection testing guided by risk. Imaging may reveal a subdural collection, tumour, hydrocephalus or major vascular disease. Treatable contributors can coexist with neurodegeneration, so improvement after one correction does not automatically settle the diagnosis; reassess cognition and function over time.
Are antipsychotic medicines routine treatment for agitation in dementia?
No. Agitation should first trigger assessment for delirium, pain, constipation, infection, hunger, fear, environmental overload, communication difficulty and carer stress. Use personalised non-drug strategies. Antipsychotics carry stroke, mortality, sedation, fall and movement risks and are generally reserved for risk of harm or severe distress from agitation, hallucinations or delusions after discussion of benefits and harms. If used, the prescription needs the lowest effective dose, shortest duration and frequent review, with particular caution in Lewy body or Parkinson-related dementia.
When should a person with suspected dementia receive urgent rather than routine assessment?
Urgent assessment is needed for sudden or fluctuating confusion, altered consciousness, fever, hypoxia, severe metabolic disturbance, new focal neurological signs, seizure, head injury or rapid progression over weeks to a few months. Immediate safety threats include suicidal intent, inability to eat or drink, unsafe swallowing, repeated dangerous wandering, violence, overdose and suspected abuse. A chronic dementia label should never explain away an acute change. Stabilise medical problems first and provide the receiving team with baseline function, onset, medicines and collateral history.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic